StemCell Therapy

Diabetes should be considered as a risk factor for the rapid progression and bad prognosis of COVID19, researchers have said.

A Chinese team have been looking at whether diabetes might influence the progression and prognosis of coronavirus by studying a total of 174 consecutive people with coronavirus.

All the participants had their demographic data, medical history, symptoms and signs, laboratory findings, chest computed tomography (CT) as well the treatment measures collected and analysed.

The research team said that people with diabetes who tested positive with COVID19, who did not have other comorbidities, were at higher risk of severe pneumonia, release of tissue injuryrelated enzymes, excessive uncontrolled inflammation responses and hypercoagulable state associated with dysregulation of glucose metabolism.

Rapid deterioration

Furthermore, serum levels of inflammationrelated biomarkers such as IL6, Creactive protein, serum ferritin and coagulation index, Ddimer, were significantly higher (P <.01) among those with diabetes, compared with those without, suggesting that people with diabetes are more susceptible to an inflammatory storm eventually leading to rapid deterioration of COVID19.

The researchers concluded: Our data supports the notion that diabetes should be considered as a risk factor for a rapid progression and bad prognosis of COVID19.

More intensive attention should be paid to patients with diabetes, in case of rapid deterioration.More intensive attention should be paid to patients with diabetes, in case of rapid deterioration.

To read the study in full, click here.

Picture credit: Shane

See more here:
Diabetes should be considered as 'risk factor' for COVID-19 rapid progression - The Diabetes Times

This entry was posted on April 30, 2020 at 2:46 pm and is filed under Diabetes. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |